摘要
目的评价氨溴特罗联合阿奇霉素治疗支原体肺炎患儿的疗效。方法支原体肺炎患儿140例,分为观察组和对照组。对照组采用阿奇霉素治疗,观察组采用阿奇霉素联合氨溴特罗治疗。结果观察组总有效率为95.71%高于对照组85.71%,差异有统计学意义(P<0.05)。两组支原体肺炎患儿均未见严重不良反应事件。结论氨溴特罗联合阿奇霉素治疗支原体肺炎患儿疗效可靠。
Objective To evaluate of the efficacy about ambroxol hydrochloride and clenbuterol hydro- chloride combined with azithromycin treatment of mycoplasma pneumonia in children. Methods 140 patients with mycoplasma pneumonia in children divided into the observation group and the control group. The control group:azithromycin treatment. The observer group:ambroxol hydrochloride and clenbuterol hydrochloride com- bined with azithromycin treatment. Results The total efficiency of the observation group was 95.71% higher than 85.71% in the control group, with significant difference (P 〈 0. 05). The two group found no serious ad- verse reaction cases. Conclusion It's good efficacy that ambroxol hydrochloride and clenbuterol hydrochloride combined with azithromycin treatment of mycoplasma pneumonia in children.
出处
《中国实用医药》
2012年第12期55-56,共2页
China Practical Medicine
关键词
小儿
支原体肺炎
阿奇霉素
氨溴特罗
Pediatric
Mycoplasma pneumonia
Azithromycin
Ambroxol hydrochloride and clenbuterol hydrochloride